EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

AFP Stimulates Glucose Metabolic Reprogramming Contributing to Hepatocellular Carcinoma Resist Sorafenib Through Activating PI3K / AKT Signalling Pathway

Yuli Zhou iD, Siren Feng iD, Yi Chen iD, Bo Lin iD, Wei Li iD, Xu Dong iD, Kun Liu iD, Qiushi Yin iD, Mengsen Li iD, Mingyue Zhu iD

Journal of Cellular and Molecular Medicine · 2026-06 · 30 (11)

DOI: 10.1111/jcmm.71226 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, online erschienen am 04.06.2026. Verfasst von Yuli Zhou und 9 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Tropical Translational Medicine, Ministry of Education, and Hainan Provincial Key Laboratory of Carcinogenesis and Intervention, Sc…. Hauptthemen laut MEDLINE: alpha-Fetoproteins, Carcinoma, Hepatocellular, Drug Resistance, Neoplasm, Glucose. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, The Natural Science Foundation of Hainan Province, Hainan Provincial Science and Technology Special Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alpha fetoprotein (AFP) regulates glucose metabolism reprogramming (GMR) related to drug resistance of hepatocellular carcinoma (HCC) and remains unclear. This study explores the effect of AFP regulating GMR (Glucose metabolic reprogramming) on the tolerance of HCC cells to sorafenib. Thirty clinical liver cancer samples and multi‐omics databases were collected; the expression of AFP, GMR‐related proteins, pyruvate kinase M2 (PKM2), and the PI3K/AKT signalling pathway‐associated proteins were assessed using immunohistochemistry (IHC) or Western blotting. MTT, cloning assays, flow cytometry, and TUNEL were performed to evaluate the effects of AFP on HCC resistance to sorafenib. Alterations in glucose consumption, lactate dehydrogenase activity, and ATP production were measured. Co‐immunoprecipitation and immunofluorescence experiments were conducted to determine how AFP interacts with PKM2. An in vivo mouse tumour model was used to investigate the restoration of tumorigenesis and development. The results indicated that AFP inhibited sorafenib‐induced apoptosis of HCC cells. AFP activated the PI3K/AKT signalling pathway to promote the GMR‐related protein expression and enzyme activity. Particularly, AFP's interaction with PKM2 stimulated the activity of PKM2 to enhance GMR, contributing to HCC resistance to sorafenib. In vivo experiments demonstrated that inhibition of AFP expression attenuated tumorigenesis and growth, and this effect was restored by overexpression of PKM2; PKM2 played a critical activated role in AFP mediating the GMR in HCC. In conclusion, AFP activates the PI3K/AKT signalling pathway to augment aerobic glycolysis in HCC cells, leading to HCC resistance to sorafenib. Inhibition of AFP expression and targeting of PKM2 may represent a novel approach for clinically reversing sorafenib tolerance in HCC patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

alpha-FetoproteinsCarcinoma, HepatocellularDrug Resistance, NeoplasmGlucoseLiver NeoplasmsMetabolic ReprogrammingSorafenibAnimalsHumansMaleMiceApoptosisCarrier ProteinsCell Line, TumorGene Expression Regulation, NeoplasticMembrane ProteinsMice, NudePhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktSignal Transduction

Stichwörter der Autor:innen

PI3K/AKT signalling pathwayalpha fetoproteindrug resistanceglucose metabolic reprogramminghepatocellular carcinoma

Substanzen

alpha-FetoproteinsCarrier ProteinsGlucoseMembrane ProteinsPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktSorafenib

Autor:innen und Institutionen

  • Key Laboratory of Tropical Translational Medicine, Ministry of Education, and Hainan Provincial Key Laboratory of Carcinogenesis and Intervention, School of Basic Medical Sciences, Hainan Medical University, Haikou, Hai…
  • Department of Medical Oncology, Second Affiliated Hospital, Hainan Medical University, Haikou, Hainan Province, P.R. China.

ORCID-Profile: Yuli Zhou, Siren Feng, Yi Chen, Bo Lin, Wei Li, Xu Dong, Kun Liu, Qiushi Yin, Mengsen Li, Mingyue Zhu

Förderung

  • National Natural Science Foundation of China
  • The Natural Science Foundation of Hainan Province
  • Hainan Provincial Science and Technology Special Fund
  • Joint Project of Hainan Provincial Health Science and Technology
  • Hainan Provincial Graduate Innovation Project

Zitieren

APA

Zhou, Y., Feng, S., Chen, Y., Lin, B., Li, W., Dong, X., Liu, K., Yin, Q., Li, M., & Zhu, M. (2026). AFP Stimulates Glucose Metabolic Reprogramming Contributing to Hepatocellular Carcinoma Resist Sorafenib Through Activating PI3K / AKT Signalling Pathway. Journal of Cellular and Molecular Medicine, 30(11). https://doi.org/10.1111/jcmm.71226

Vancouver

Zhou Y, Feng S, Chen Y, Lin B, Li W, Dong X, et al. AFP Stimulates Glucose Metabolic Reprogramming Contributing to Hepatocellular Carcinoma Resist Sorafenib Through Activating PI3K / AKT Signalling Pathway. Journal of Cellular and Molecular Medicine. 2026;30(11). doi:10.1111/jcmm.71226

BibTeX
@article{Zhou2026,
  author = {Zhou, Yuli and Feng, Siren and Chen, Yi and Lin, Bo and Li, Wei and Dong, Xu and Liu, Kun and Yin, Qiushi and Li, Mengsen and Zhu, Mingyue},
  title = {AFP Stimulates Glucose Metabolic Reprogramming Contributing to Hepatocellular Carcinoma Resist Sorafenib Through Activating PI3K / AKT Signalling Pathway},
  journal = {Journal of Cellular and Molecular Medicine},
  year = {2026},
  volume = {30},
  number = {11},
  doi = {10.1111/jcmm.71226}
}
Kostenlos starten →